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Abstract- A screen printed carbon electrode (SPCE) containing the electrocatalyst Meldola’s 
Blue (MB) has been investigated as the base transducer for a glutamate biosensor. The 
sandwich biosensor was fabricated by firstly depositing a chitosan (CHIT) layer onto the 
surface of the transducer (MB-SPCE), followed by glutamate dehydrogenase (GLDH): this 
device is designated GLDH-CHIT-MB-SPCE. NAD+ was added to buffer solutions prior to 
the measurement of glutamate.  This biosensor was used in conjunction with amperometry in 
stirred solution at an applied potential of +0.1 V (vs. Ag/AgCl). Optimum conditions for the 
analysis of glutamate were found to be as follows: temperature, 35 °C; buffer, pH 7; ionic 
strength, 75 mM; NAD+, 4 mM; CHIT 0.05% in 0.05 M HCl; GLDH, 30 U. The linear range 
of the biosensor was found to be 12.5 µM to 150 µM, the calculated limit of detection (based 
on three times signal to noise) was 1.5 µM and the sensitivity was 0.44 nA/µM. The proposed 
biosensor was used to measure glutamate in serum before and after fortification with 
glutamate. The endogenous concentration of glutamate was found to be 1.68 mM and the 
coefficient of variation (CV) was 4.1%. The serum was then fortified with 2 mM of 
glutamate, and the resulting mean recovery was 96% with a CV of 3.3% (n=6). An unfiltered 
beef OXO cube was analysed for monosodium glutamate (MSG) content. The endogenous 
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content of MSG was 125.43 mg/g with a CV of 8.98%. The OXO cube solution was fortified 
with 0.935 g (100 mM) of glutamate, the resulting mean recovery was 91% with a CV of 
6.39%.  
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1. INTRODUCTION  
Glutamate is one of the most abundant excitatory neurotransmitters and is involved in 
fundamental neurological processes such as the formation of memories and learning [1]. 
Deficiencies or abnormalities in the behaviour of neurological pathways that utilize glutamate 
and its receptors are associated with neurological disorders such as Alzheimers [2], 
schizophrenia [3] and depression [4]. 
Glutamate is also a key compound in nitrogen metabolism, protein synthesis and 
degradation, and is of great physiological importance. It is the most abundant intracellular 
amino acid with concentrations varying between 2 and 20 mM [5],  whilst estimated 
extracellular levels of L-glutamate are around 150 µM in plasma and 10 µM in cerebrospinal 
fluid [6,7].  
Glutamate metabolism is linked with the citric acid cycle [8], GABA synthesis [9] and 
urea cycle [10]. It is also linked to amino acid degradation as glutamate dehydrogenase 
(GLDH) catalyses the elimination of amino groups from amino acids. GLDH catalyses the 
oxidative deamination of glutamate to 2-oxoglutarate, using nicotinamide adenine 
dinucleotide (NAD+) as a cofactor (Eq.1) [11]. It is a reversible reaction, which typically 
favours glutamate formation in mammals [12]. 
 Glutamate + NAD+ + H2O ↔ 2-oxoglutarate + NADH + NH4+ + H+                         (Eq. 1) 
Genetically expressed defects in glutamate metabolism have been recently discovered and 
lead to hyperinsulinism/hyperammonemia syndrome [13]. L-glutamate, in the form of 
monosodium glutamate (MSG), also has widespread use as a flavour-enhancing food 
additive, commonly found in Chinese food and is linked to Chinese Restaurant Syndrome 
(CRS) [14]. Thus the analysis and determination of L-glutamate is important for both food 
and clinical applications.  
The measurement of glutamate has been carried out using various analytical techniques 
such as HPLC [15,16], capillary electrophoresis [17] and enzyme recycling in conjunction 
with microfluidic [18] and  spectrophotometric [19]  techniques. In the present study we 
wished to explore the possibility of developing an amperometric biosensor for glutamate 
measurements. This device would offer reliability, convenience and low cost, particularly 
when fabrication was performed using screen-printing technology. We previously reported on 
the development of amperometric biosensors based on dehydrogenase enzymes, for lactate 
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[20,21], alcohol [22], glucose [23] and NH4+ [24,25]. These devices were based on a screen 
printed carbon electrode (SPCE) incorporating the electrocatalyst Meldola’s Blue (MB-
SPCE). MB reduces the overpotential for the detection of NADH, which is formed during the 
operation of the biosensor. Applied potentials close to 0 V vs. Ag/AgCl are possible. In a 
previous paper [25] we reported on a electrochemical NH4+ biosensor based on the reaction 
of this species with 2-oxoglutarate and NADH in the presence of the enzyme GLDH. 
Consequently, we considered that the development of a glutamate biosensor should be 
feasible by immobilizing GLDH onto the surface of a MB-SPCE and driving the overall 
reaction in the opposite direction by incorporating the oxidised cofactor (NAD+) with the 
enzyme . 
In this study we have investigated an immobilising procedure involving chitosan (CHIT). 
Chitosan is a linear hydrophilic polysaccharide composed of n-acetyl-D-glucosamine and  
D-glucosamine units which are linked with ß-(1-4) glycosidic bonds. It is a biocompantible, 
inexpensive, non-toxic biopolymer with excellent film forming properties [26] and can 
therefore be employed for enzyme immobilisation. The application of chitosan as an enzyme 
immobilization matrix has been reported previously for many different enzymes [27]. 
In the present paper we describe the development and application of a GLDH-CHIT-MB-
SPCE biosensor for the determination of glutamate in serum and glutamate as MSG in food 
(OXO cubes). 
 
2. MATERIALS AND METHODS 
2.1. Chemicals and reagents 
All chemicals were of analytical grade, purchased from Sigma Aldrich, UK, except 
glutamate dehydrogenase (CAT: 10197734001) which was purchased from Roche, UK. The 
75 mM phosphate buffer (PB) was prepared by combining appropriate volumes of tri-sodium 
phosphate dodecahydrate, sodium dihydrogen orthophosphate dehydrate and disodium 
hydrogen orthophosphate dehydrate solutions to yield the desired pH. Glutamate and 
NADH/NAD+ solutions were prepared in 75 mM PB. 0.05% of chitosan was dissolved in 
0.05 M HCl following up to 10 minutes sonication. Bovine serum albumin (BSA) (obtained 
from AbD Serotec) was used to create dummy electrodes by drop-coating the same 
equivalent protein mass as glutamate dehydrogenase. Fetal bovine serum (FBS) (South 
American Origin, CAT: S1810-500) obtained from Labtech Int. Ltd, was used for serum 
analysis. Food samples (Beef OXO cubes) were obtained from a local supermarket.   
 
2.2. Apparatus 
All electrochemical experiments were conducted with a three-electrode system consisting 
of a carbon working electrode containing MB-SPCE (Gwent Electronic Materials Ltd; Ink 
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Code: C2030519P5), Ag/AgCl reference electrode (GEM Product Code C61003P7):  printed 
onto PVC, and a separate Pt counter electrode. The area of the working electrode was defined 
using insulating tape, into a 3×3 mm square area. The electrodes were then connected to the 
potentiostat using gold clips. Solutions, when required, were stirred using a circular magnetic 
stirring disk and stirrer (IKA® C-MAG HS IKAMAG, Germany) at a fixed speed. A 
µAutolab II electrochemical analyser with general purpose electrochemical software GPES 
4.9 was used to acquire data and experimentally control the voltage applied to the SPCE in 
the 10 ml electrochemical cell. An AMEL Model 466 polarographic analyser combined with 
a GOULD BS-271 chart recorder was used for some amperometric studies. Measurement and 
monitoring of the pH was conducted with a Fisherbrand Hydrus 400 pH meter (Orion 
Research Inc., USA). Sonications were performed with a Devon FS100 sonicator 
(Ultrasonics, Hove, Sussex, UK). 
 
2.3. Procedures 
2.3.1. Fabrication of glutamate biosensor  
A 0.05% HCl solution containing CHIT was drop-coated onto the surface of the 
unmodified MB-SPCE 9 mm2 working electrode and left to dry under vacuum. Once dried 
the enzyme GLDH with the appropriate quantity of units was drop-coated directly onto the 
CHIT layer. The same procedure was used to obtain dummy biosensors by using CHIT and 
the same mass of BSA as that of the enzyme. Fig. 1 illustrates the proposed GLDH-CHIT-
MB-SPCE biosensor.  The biosensors were stored in a desiccator, shielded from light at 4 ºC 
overnight to allow the enzyme layer to dry. 
 
 
 
Fig. 1. Diagram of proposed biosensor strip; the insulating tape defines both the WE and RE. 
CHIT is then drop-coated and allowed to dry, followed by GLDH. All studies were 
conducted using a separate Pt wire counter electrode 
 
Anal. Bioanal. Electrochem., Vol. 6, No. 4, 2014, 435-449                                                  439 
 
Serum and food samples were analysed (n=3) for interferences using dummy biosensors.  
If interferences were detected, the average signal generated was deducted from the enzyme 
biosensor response.  
 
2.3.2. Calibration studies of the biosensor using amperometry in stirred solution 
All amperometric measurements were performed in stirred solutions using an applied 
potential of +0.1 V vs. Ag/AgCl. Measurements of glutamate were conducted in 75 mM PB 
(pH 7.0) containing 4 mM of NAD+ and 50 mM NaCl using the GLDH-CHIT-MB-SPCE. 
The biosensor was immersed into a stirred 10 mL buffer solution, the potential applied and 
sufficient time was allowed for a steady-state current to be obtained. The amperometric 
responses to additions of known concentrations of glutamate were then recorded. 
Amperometry was used to determine the effects of pH (5–9) and temperature (25-40 °C) by 
examining the performance characteristics over the concentration range of 25 µM to 300 µM 
glutamate.  
 
2.3.3. Application of optimised amperometric biosensor (GLDH-CHIT-MB-SPCE) to the 
determination of glutamate in food 
OXO cubes (5.9 g, average mass of three OXO cubes) were prepared by dissolving one 
cube in 50 mL of PB and sonicating for 15 minutes. The endogenous concentration of MSG 
was determined by using the method of standard addition. An initial 10 µl volume of the 
dissolved OXO cube was added to the stirred buffered solution (10 mL) in the voltammetric 
cell containing the biosensor, operated at +0.1 V with subsequent standard additions of 10 µL 
of 25 mM glutamate. 
The reproducibility of the biosensor assay for MSG analysis in OXO cubes was 
determined by repeating the whole procedure six times with six individual biosensors. The 
effects of interferences from the OXO cube were established by using a dummy BSA 
biosensor and deducted from the enzyme biosensor signal.  
The recovery of MSG added to OXO cubes was investigated by fortifying the solution 
containing one OXO cube with 100 mM of glutamate. The analysis of this solution was 
performed in a similar manner to that described for the unfortified solution. In this case, an 
aliquot of only 2 µL of the fortified OXO solution was added to 10mL volumes of buffer 
solution. Standard additions of 2.5 µL of 100 mM glutamate were added to this mixture.  
 
2.3.4. Application of optimised amperometric biosensor (GLDH-CHIT-MB-SPCE) to the 
determination of glutamate in serum 
To determine the original glutamate concentration, an initial volume of 100 µL of serum 
was added to 9.9 mL of buffered solution. The serum solution was subjected to amperometry 
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in stirred solution using an applied potential of +0.1 V vs. Ag/AgCl. This was followed by 
additions of 10 µL aliquots of 25 mM standard glutamate solution to the voltammetric cell. 
The currents resulting from the enzymatic generation of NADH were used to construct 
standard addition plots, from which the endogenous concentration of glutamate was 
determined. The reproducibility of the biosensor was deduced by repeating the studies six 
times with six individual biosensors. 
The procedure was repeated using serum spiked with 2 mM glutamate (n=6) to determine 
the recovery of the assay. The effects of the interference from serum were established by 
using a dummy BSA biosensor. A dummy biosensor was constructed by drop coating the 
equivalent weight of the enzyme with BSA.  
 
3. RESULTS AND DISCUSSION 
3.1. Principle of Operation of the Biosensor 
The overall principle of operation of the biosensor is shown in Fig. 2. Glutamate in 
solution is oxidised to form 2-oxoglutarate in the presence of the immobilized enzyme 
glutamate dehydrogenase (GLDH) and NAD+; the product NADH and NH4+ are formed 
during this reaction (Eq. 1).  The NADH diffuses through the CHIT layer to reach the 
electrode (Fig. 1), where it undergoes oxidation by the MBox which is reduced to MBred. The 
electrochemical oxidation of MBred to MBox occurs at an applied potential of +0.1 V vs. 
Ag/AgCl and produces the analytical response (Fig. 2). The value of +0.1 V was deduced by 
constructing a hydrodynamic voltammogram and selecting the potential from the position of 
the plateau (Fig. 3). 
 
 
 
 
Fig. 2. Schematic displaying the interaction between the immobilized enzyme GLDH and 
glutamate at the surface of the electrode and the subsequent generation of the analytical 
response 
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Fig. 3. Hydrodynamic voltammogram plot of GLDH-CHIT-MB-SPCE in the presence of 1 
mM NADH, in 10 mL of supporting electrolyte; 75 mM, PB (pH 7.0) and 50 mM NaCl  
  
3.2. Immobilisation of GLDH using chitosan 
During initial studies when drop-coating the GLDH onto the surface of the MB-SPCE 
alone, steady-state currents were not produced. Additions of glutamate produced inconsistent 
currents, suggesting that the GLDH may have been dissipating into the free solution, 
producing sporadic current responses. Studies were conducted to investigate the use of 
glutaraldehyde and cellulose acetate; both commonly used enzyme binding agents, failed to 
generate steady-state currents or produced little to no signal response, indicating loss of 
enzyme into solution. CHIT was therefore applied to the surface of the biosensors to fabricate 
GLDH-CHIT-MB-SPCE devices; subsequent additions of glutamate produced consistent 
steady state responses with this approach. 
 
3.3. Optimisation Studies 
The response of the GLDH-CHIT-MB-SPCE biosensor to changes in temperature was 
investigated using concentrations of glutamate over the range 12.5 to 250 µM prepared in 75 
mM phosphate solution (pH 7.0). The effect of temperatures between 25 to 40 °C was 
studied. The maximum amperometric response was found to occur at 35°C (Fig. 4A). The 
decrease occurring above 35 °C may be due to enzyme denaturing at higher temperatures. It 
may be noted that the linear range was highest using 30 °C which could be beneficial in some 
applications.  
The effect of pH was investigated over the pH range 5–9 (Fig. 4B). The highest 
sensitivity (0.18 nA/µM) was obtained at pH 9, with a near-linear decrease down to a pH of 
400
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5. However, the linearity of the responses showed an inverse trend with the greatest linear 
range occurring at pH 5, decreasing down to a pH of 9. 
 
 
 
 
 
 
                                                                          (A) 
 
 
                                                                              (B) 
Fig. 4. A. Illustrates the effects of temperature upon the current response of the biosensor to 
injections of glutamate up to 275 µM in 25 µM steps. B. Illustrates the effects of pH upon the 
current response of the biosensor to the addition of glutamate. An applied potential +0.1 V vs. 
Ag/AgCl in 10 ml of 75 mM phosphate buffer solution containing 50 mM NaCl was used. 
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3.4. Calibration Studies 
Calibration studies with glutamate were conducted with the fully developed glutamate 
biosensor using the optimized experimental conditions over the concentration range 25µM–
275 µM. The biosensor exhibited a sensitivity of 0.44 nA/µM. The calculated limit of 
detection (based on three times signal-to-noise) was 1.5 µM, thus the biosensor is clearly 
appropriate for analysing extracellular concentrations of glutamate in clinical applications.  
 
3.4.1. Application of the optimum amperometric biosensor (GLDH-CHIT-MB-SPCE) to the 
determination of glutamate in unspiked and spiked food 
Many food products are known to contain MSG as a flavour enhancer, therefore, we 
decided to explore the possibility of applying our new glutamate biosensor to a known brand 
of beef stock cube.  
A standard addition study was conducted by dissolving one OXO cube (5.916 g mass) in 
50 ml of PB using sonication for 15 minutes. Six replicate OXO cube samples were analysed 
using fresh biosensors for each measurement. The determination was performed by filling the 
cell with 9.99 mL of electrolyte, establishing a steady state current, and then injecting a 10 
µL volume of unfiltered OXO cube in PB solution with subsequent 10 µL injections of 25 
mM glutamate (Fig. 5A). The mean quantity of glutamate discovered in unspiked OXO cubes 
(n=6) was 125.43 mg/g with a coefficient of variation of 8.98%. Results are shown in Table 
1. A standard addition calibration plot is shown in Fig 5B.  
GLDH-CHIT-MB-SPCE biosensors were used to determine glutamate in spiked OXO 
cubes. The OXO cube was spiked with 100 mM of glutamate, doubling the endogenous level 
of glutamate found in OXO cube stock. The standard addition method employed for the 
unspiked OXO cubes was altered by changing the initial injection of spiked OXO cube 
solution to 2 µL. The mean recovery (n=6) was a 91% with a CV of 6.39% (Table 1.) This 
result indicated high reproducibility for biosensors in what was a complex, unfiltered 
medium. Interestingly the endogenous content of MSG in OXO cubes measured by our 
biosensor, gave similar values for stock cubes containing MSG analysed by both HPTLC [28] 
and an optical biosensor [29]; values of 133.50 mg/g and 182.9 mg/g were detected by the 
named methods respectively. 
 
3.4.2. Application of the optimum amperometric biosensor (GLDH-CHIT- MB-SPCE) to the 
determination of glutamate in both unspiked and spiked serum 
Amperometry, in conjunction with the method of multiple standard additions was 
conducted to determine the endogenous levels of glutamate and the recovery for serum 
spiked with additional glutamate. The replicate serum samples were analysed using a fresh 
biosensor for each measurement.  
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The data obtained on serum samples using the glutamate biosensor are shown in Table 2. 
The endogenous levels of glutamate detected were 1.68 mM for the unspiked samples. The 
coefficient of variation was 4.09% for the six individual samples. This concentration is above 
that discovered by Ye and Sontheimer in 1998 [30] who discovered concentrations ranging 
from 808.2 µM to 1195.7 µM in fetal bovine (calf) sera (FBS) using a bioluminescence 
detection method. However, this study did not include the provider of serum nor the South 
American variety used in studies conducted using the GLDH-CHIT-MB-SPCE biosensor, 
thus glutamate concentrations may potentially be higher in different batches given the 
variation displayed. These results show promise due to the low coefficient of variation, small 
amount of serum required to carry out analysis and the lack of preparation steps. 
 
 
 
Fig. 5. A. Amperogram obtained using a GLDH-CHIT-MB-SPCE with a solution containing 
10 µL of a dissolved OXO cube; arrows indicate additions of 10 µL of 25 mM glutamate into 
a 10 mL volume. Measurements taken 1.5 min after each addition. B. Typical standard 
addition calibration plot obtained with a solution containing a dissolved OXO cube using a 
GLDH-CHIT-MB-SPCE 
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Table 1. Data obtained from the unspiked and spiked OXO cube/food study. The mean 
endogenous concentration was 125.43 mg/g (n=6) in unspiked OXO cubes. The mean 
recovery was 91%, coefficient of variation of 6.39% indicating a good level of 
reproducibility in a complex unfiltered media (n=6) 
 
 
Unspiked OXO Cube  
 
Sample Quantity of Glutamate 
Detected (mg/g) 
 
1 114.15 
2 147.29 
3 129.37 
4 113.96 
5 125.47 
6 122.35 
  
Mean (mg/g) 125.43 
Std Dev 11.26 
CV (%) 8.98 
 
 
 
Spiked OXO Cube  recovery 
 
   
Sample Endogenous 
Concentration 
(mg/g) 
 
Spike (mg/g) Total Concentration Found 
(mg/g) 
Recovery 
(%) 
1 125.43 158.03 266.05 86 
2 125.43 158.03 268.20 88 
3 125.43 158.03 280.11 97 
4 125.43 158.03 279.03 96 
5 125.43 158.03 273.73 92 
6 125.43 158.03 262.15 83 
Mean (%) 91 
Std Dev 6.00 
CV (%) 
 
6.39 
 
The GLDH-CHIT-MB-SPCE biosensors were then used to determine glutamate in spiked 
serum. The serum was spiked with 2.00 mM glutamate so as to roughly double the 
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endogenous levels of glutamate and allow a distinction between the spike and endogenous 
levels. The results are shown in Table 2. The mean recovery (n=6) was 96% with a CV of 
3.29% indicating high reproducibility in serum. This method offers an economical and simple 
approach for the screening of glutamate levels in serum.  It should be mentioned that the 
biosensors were stored in a desiccator in a refrigerator at 4 °C before use; under these 
conditions they were found to be stable for at least one week.  
The GLDH-CHIT-MB-SPCE biosensor described in this paper possesses a superior limit 
of detection by comparison to other biosensors utilising glutamate dehydrogenase and can be 
fabricated simply in comparison to those reported previously (Table 3). Consequently, these 
devices hold promise for application quality control in clinical laboratories. It is interesting to 
note that a biosensor based on glutamate oxidase [31] has been reported for the determination 
of glutamate in soy sauce; a detection limit of 10 nM was achieved. However, it should be 
mentioned that the operating potential required to detect H2O2 was +950 mV, as a result the 
selectivity of the device may not be sufficient for the analysis of glutamate in serum.  
 
Table 2. Data obtained from the unspiked and spiked serum study. In unspiked serum, 1.68 
mM of glutamate was detected (n=6) with a coefficient of variation of 4.1%. In spiked serum, 
the mean recovery was 96%, coefficient of variation 3.29% (n=6). 
 
 
Unspiked Serum  
 
Sample Concentration of Glutamate 
detected (mM) 
1 1.70 
2 1.54 
3 1.67 
4 1.76 
5 1.69 
6 1.71 
Mean (mM) 1.68 
Std Dev 0.07 
CV (%) 
 
4.10 
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Spiked Serum  
 
   
Sample Spike  
(mM) 
Endogenous 
Concentration 
(mM) 
Total Concentration 
Found (mM) 
 
Recovery (%) 
1 2.00 1.68 3.52 92 
2 2.00 1.68 3.65 98 
3 2.00 1.68 3.62 97 
4 2.00 1.68 3.65 99 
5 2.00 1.68 3.62 97 
6 2.00 1.68 3.49 90 
Mean (%) 96   
Std Dev 3.14 
CV (%) 3.29 
 
Table 3. A comparison of previously reported Glutamate biosensors including the one 
described in this paper 
 
4. CONCLUSION 
This paper has demonstrated the effective use of CHIT to immobilise GLDH onto the 
surface of a MB-SPCE for the fabrication of a glutamate biosensor and the successful 
Immobilization Method 
 
Ref. LOD Optimal 
pH 
Applied 
Voltage 
[NAD+]  Sensitivity Linear 
Range 
Response 
Time 
GDH attached to the inner 
surface of a 75µM i.d. 
capillary using biotin-
avidin chemistry. NADH 
measured by fluorescence. 
[32] 3 µM 
8.5, but 
saline 7.3 
also used. 
- 3 mM - - 450 ms 
Glassy carbon covered in 
CNT-CHIT-MDB 
composite film. GDH in 
PBS was caste on the 
CNT composite electrode. 
[33] 2 µM  7.2 -100 mV 4 mM 0.71 ± 0.08 
nA/µM N/A ~10 s 
GDH and diaphorase 
immobilized on a 
nanocompositie electrode. 
[34] 5.4 µM 9.0 +300 mV 2 mM 28 nA µM 
−1cm−2 
10 - 3495µM - 
Polymer-modified 
electrode. MB entrapped 
into two polymers 
[35] 2 µM  7.4 0 mV 1 mM 0.70 nA µM-1 0 – 100 µM  
Nanomolar Detection of 
Glutamate at a biosensor 
based on Screen-printed 
Electrodes modified with 
Carbon Nanotubes 
[31] 10 nM 7.4 +950 mV N/A 
0.72nA ± 
0.05 µA 
µM-1 
0.01 – 10 µM <5 s 
GLDH-CHIT-MB- SPCE 
 
This 
study 1.5 µM  7.0 +100 mV 4 mM 
0.44 
nA/µM 
12.5 - 150 
µM 
~2 s  
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application of the biosensor to the determination of glutamate, in both serum and food 
samples, without any sample pre-treatment, other than dilution.  
This simple approach is attractive as it is based on an electrochemical biosensor 
fabricated by incorporating biological compounds with a chemically modified screen printed 
carbon electrode. SPCE’s can be mass produced at low cost so biosensors based on this 
technology can be considered disposable. This latter feature may be of significance in 
biological fluid analysis where contamination may be an issue. 
In summary our proposed biosensor approach offers the advantages of good selectivity 
owning to the combination of an enzyme integrated with a transducer operated at a low 
potential of only +100 mV, coupled with the simplicity of fabrication and analytical 
operation.  
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